Boston wants to limit GLP-1 coverage for city workers amid health care costs, budget crisis – The Boston Globe

The injectable GLP-1 weight loss drug Ozempic, pictured in July 2023.

The city’s chief financial officer, Ashley Groffenberger, sent a letter to the City Council on Monday saying that health insurance rates for city employees are increasing nearly 23 percent in the fiscal year that begins in July — the highest year-over-year premium costs the city has seen “in recent history.” According to the city, Boston … Read more